BiotechPark with Innovation- and Incubationscenter
Berlin-Buch, with its long tradition of excellent biomedical basic and clinical research as well as clinical expertise, is an ideal environment for life science companies. The campus atmosphere is conducive to scientific exchange, technology transfer and collaborative projects.
With an area of approximately 45,000 m², the BiotechPark Berlin-Buch is one of the largest biotech parks in Germany. Here entrepreneurs and companies find affordable, industry-specific laboratory and office space with state-of-the-art facilities. Start-ups can grow and thrive in the Innovation and Incubation Center, building areas on the Campus allow for future development. The managing company, Campus Berlin-Buch GmbH, supports the companies in all matters and provides comprehensive service.
Currently, 75 companies are located on campus and employ around 850 people. More than fifty of these companies are in the biotech sector, several others offer services for the life science industry. Since 1998 the number of employees of the biotech companies has more than doubled.
The business fields of the companies range from medical technology products, molecular biological diagnostics and treatments, preclinical pharmacological and pharmacogenomic tests, RNA technologies, the search for pharma-relevant target molecules, production and testing of drugs and the analysis and synthesis of biomolecules.
Since 2023 the new BerlinBioCube start-up center in BiotechPark Berlin-Buch offers an additional 8,000 square meters of laboratory and office space and attractive services for start-ups in the fields of biotechnology and medical technology as well as adjacent areas.
„Made in Buch“ stands for high quality and innovation in the life sciences. Selected products can be found here.
News innovation
Eckert & Ziegler and TerThera Sign Supply Agreement to Bring Next-Generation GMP Terbium-161 Radiopharmaceutical Therapies to Brazilian Patients
Eckert & Ziegler Brazil, a regional subsidiary of the global nuclear medicine group Eckert & Ziegler SE (ISIN DE0005659700, TecDAX), and TerThera announced today the signing of a strategic supply agre...
more ...Award for entrepreneurial spirit: Christian Hackenberger receives the UNIPRENEURS Prize
Prof. Dr. Christian Hackenberger of the Leibniz Forschungsinstitut für Molekulare Pharmakologie (FMP) at the Campus Berlin-Buch and Humboldt University of Berlin has been awarded the UNIPRENEURS Prize...
more ...“The coolest part is vortexing”
One week, two topics, and plenty of new experiences: 25 young people take a deep dive into research on rare diseases and immunology at the Life Science Learning Lab “Gläsernes Labor,” including by ana...
more ...Events Campus
04.11.2026, 16:00
Plastik im Kopf: Nanoplastik findet sich auch in unserem Gehirn. Welchen Einfluss hat das auf die Zellfunktionen unseres Zentralorgans?
Vorlesungsreihe: Neue Wege in der Biomedizin: Aktuelle Forschungsthemen vom Campus Berlin-Buch
more ...05.11.2026, 14:00
Neurobiologie - Forschung und neue Therapieansätze
Fortbildungsveranstaltung der Neurowissenschaftlichen Gesellschaft e.V. in Zusammenarbeit mit VBIO, Gläsernem Labor, Max Delbrück Center und Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FM...
more ...12.11.2026, 17:00
Talk in the Cube: Cooperation in Life Science with the United States
This Talk in the Cube covers essential legal topics for German companies looking to expand into the U.S. market: Setting up a business in the U.S, immigration law, product liability etc.
more ...